This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (1) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Anderson, M Articles by Larson, D. Search for Related Content PubMed PubMed Citation Articles by Anderson, M Articles by Larson, D. Social Bookmarking                         What's this?

Comparison of isoproterenol and dobutamine in the induction of cardiac hypertrophy and fibrosis

Circulatory Sciences Graduate Perfusion Program, The University of Arizona, Tucson, AZ, USA

D Moore

Circulatory Sciences Graduate Perfusion Program, The University of Arizona, Tucson, AZ, USA

DF Larson

Circulatory Sciences Graduate Perfusion Program, The University of Arizona, Tucson, AZ, USA dflarson{at}u.arizona.edu

Isoproterenol (Iso) was a clinical therapeutic that is now used as a research means for the induction of cardiac hypertrophy. Currently, dobutamine (Dob) has replaced Iso as the preferred inotropic β-adrenergic agent to wean patients from cardiopulmonary bypass and to sustain adequate cardiac function during the postoperative period. We sought to compare the cardiac structural and functional effects of long-term administration (7days) of Iso with Dob at a dose of 40µg/mouse/day in 12-week-old C57BL/6 female mice. Cardiac function was determined with transthoracic echo cardiography (ECHO) 24 hours after the last dose. Cardiac wet weights increased 33% and 24% in the Iso and Dob groups compared with controls (p < 0.05). Dob and Iso significantly increased cardiac fibrosis and decreased cardiac function with chronic administration. Administration also resulted in increased left atrial size, suggesting that both Dob and Iso decreased LV compliance, but did not induce heart failure. In conclusion, chronic administration of Dob may have a detrimental effect on cardiac structure and function.

Key Words: cardiac • echocardiogram • extracellular matrix • fibrosis • remodeling • β-adrenergic

Perfusion, Vol. 23, No. 4, 231-235 (2008)
DOI: 10.1177/0267659108100708


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				D Moore, M Anderson, and D. Larson Effect of clenbuterol administration on the healthy murine heart Perfusion, September 1, 2008; 23(5): 297 - 302. [Abstract] [PDF]